Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study

NCT03976336 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT03976336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03976336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Tolerability and Effects of Berberine on Major Metabolic Biomarkers: A Pilot Study
Lead sponsor
University of Kansas Medical Center
Phase
Not applicable
Overall status
Completed
Start date
August 20, 2019
Completion date
April 1, 2025
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome